Lacktman Comments on Confusion Over DEA’s Telemedicine Rulemaking

22 April 2019 Politico News
Partner Nate Lacktman was quoted in a Politico article, “HHS extends interoperability comment window,” about lingering confusion over an expected Drug Enforcement Administration rule that is supposed to clarify when doctors can register to prescribe controlled substances via telemedicine.

Lacktman said it is not clear what will be in the rule, which is expected to come out in October. If the rule isn’t specific enough or if it restricts prescribing to certain specialties or substances, clinicians might not feel comfortable prescribing virtually, he said.

Insights

Supreme Court Limits Patent Assignor Estoppel
02 August 2021
PharmaPatents
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream